All In Biotech

Drug Trial Radar · NCT06859268

A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Retatrutide Treatment in the Maintenance of Weight Reduction in Individuals With Obesity

Last checked: Nov 20, 2026Latest source record: Mar 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 643 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

643

Planned (sponsor's estimate)

Start

Mar 5, 2025

Primary completion

Apr 2028

Study completion Apr 2028

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Mar 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study of retatrutide in participants with obesity. The main purpose is to learn more about how retatrutide maintains body weight loss. The study will have two treatment phases: an 80 week lead-in phase in which all participants will take retatrutide dose 1 and a 36 week randomized, double-blinded phase in which participants will either take retatrutide dose 1, retatrutide dose 2, or switch to placebo. Participation in the study will last around 125 weeks.

Conditions

  • Obesity

Interventions

  • RetatrutideDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change from Baseline in Body WeightTime frame: Week 0, Week 116

Locations

53 sites in 3 countries. Site status is shown where the registry gives one.

  • Southern California Clinical Research

    Santa Ana, California

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • CMR of Greater New Haven, LLC

    Hamden, Connecticut

  • ALL Medical Research, LLC

    Cooper City, Florida

  • Florida International Medical Research

    Coral Gables, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Charter Research - Winter Park

    Orlando, Florida

  • Metabolic Research Institute, Inc.

    West Palm Beach, Florida

  • Kubost Clinical Research - Marietta

    Marietta, Georgia

  • North Georgia Clinical Research

    Woodstock, Georgia

  • Pacific Diabetes & Endocrine Center

    Honolulu, Hawaii

  • Alliance for Multispecialty Research, LLC

    Oak Brook, Illinois

  • Springfield Clinic Main Campus

    Springfield, Illinois

  • Alliance for Multispecialty Research, LLC

    Lexington, Kentucky

  • L-MARC Research Center

    Louisville, Kentucky

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana

  • Care Access - Lake Charles (Bayou Pines)

    Lake Charles, Louisiana

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Alliance for Multispecialty Research, LLC

    Kansas City, Missouri

  • Vector Clinical Trials

    Las Vegas, Nevada

  • Dent Neurosciences Research Center, Inc

    Amherst, New York

  • Carteret Medical Group

    Morehead City, North Carolina

  • Care Access - Raleigh

    Raleigh, North Carolina

  • Tekton Research, LLC.

    Moore, Oklahoma

  • Altoona Center For Clinical Research

    Duncansville, Pennsylvania

  • Care Access - Rapid City

    Rapid City, South Dakota

  • Alliance for Multispecialty Research, LLC

    Knoxville, Tennessee

  • Care Access - Houston

    Houston, Texas

  • Southern Endocrinology Associates

    Mesquite, Texas

  • Sleep Therapy Research Center

    San Antonio, Texas

  • National Clinical Research, Inc

    Richmond, Virginia

  • Northwest Clinical Research Center

    Bellevue, Washington

  • Central Washington Health Services Association d/b/a Confluence Health

    Wenatchee, Washington

  • Aggarwal and Associates Limited

    Brampton, Canada

  • Circulate Cardiac & Vascular Centre

    Burlington, Canada

  • Med Trust Research

    Courtice, Canada

  • Winterberry Research Inc.

    Hamilton, Canada

  • Centre de Medecine Metabolique de Lanaudiere (CMML)

    Terrebonne, Canada

  • Care Access - Thunder Bay - Barton Street

    Thunder Bay, Canada

  • Maple Leaf Research

    Toronto, Canada

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.